Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers

Journal of Pharmaceutical Sciences

Volumn 95, Issue 2, 2006, Pages 326-335

  Li, Lianli ^a,b   Mathias, Neil R ^a   Heran, Christopher L ^a   Moench, Paul ^a   Wall, Doris A ^a   Smith, Ronald L ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^b Barr Laboratories Inc   (United States)

Author keywords

Calu 3 monolayer; Carbopol; Cell culture; Epithelial delivery permeability; Mucoadhesive polymer; Nasal drug delivery; Paracellular transport

Indexed keywords

CALCIUM; CARBOMER; CELLULOSE; DESMOPRESSIN; EXCIPIENT; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MANNITOL; POLYMER; WATER;

ARTICLE; BRONCHUS MUCOSA; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CHELATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG FORMULATION; ELECTRIC RESISTANCE; EXPOSURE; EXTRACELLULAR CALCIUM; GEL; HUMAN; HUMAN CELL; MOLECULAR SIZE; NONHUMAN; RABBIT; TIGHT JUNCTION; VISCOSITY;

EID: 32644452751     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20541     Document Type: Article

References (28)

1. Gu JM, Robinson JR, Leung SH. 1988. Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carrier Syst 5:21-67.
2. Luessen HL, de Leeuw BJ, Perard D, Lehr C-M, de Boer AG, Verhoef JC, Junginger HE. 1996. Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes. Eur J Pharm Sci 4:117-128.
3. Borchard G, Leussen HL, de Boer AG, Verhoef JC, Lehr C-M, Junginger HE. 1996. The potential of mucoadhesive polymers in enhancing intestinal peptide absorption. III. Effect of chitosan glutamate and carbomer on epithelial tight junctions in vitro. J Control Rel 39:131-138.
4. Kriwet B, Kissel T. 1996. Poly(acrylic acid) micro-particles widen the intercellular spaces of Caco-2 cell monolayers: an examination by confocal laser scanning microscopy. Eur J Pharm Biopharm 42:233-240.
5. Lehr C-M, Bouwstra JA, Kok W, de Boer AG, Tukker TT, Verhoef JC, Breimer DD, Junginger HE. 1992. Effect of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat. J Pharm Pharmacol 44:402-407.
6. Luessen HL, de Leeuw BJ, Langemeyer WE, de Boer AG, Verhoef JC, Junginger HE. 1996. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improved the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res 13:1668-1672.
7. Morimoto K, Morisaka K, Kamada A. 1985. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J Pharm Pharmacol 37:134-136.
8. Witschi C, Mrsny RJ. 1999. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res 16: 382-390.
9. El-Shafy MA, Kellaway LW, Taylor G, Dickinson PA. 2000. Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits. J Drug Targeting 7:355-361.
10. Callens C, Remon JP. 2000. Evaluation of starch-maltodextrin- Carbopol® 974P mixtures for the nasal delivery of insulin in rabbits. J Control Rel 66:215-220.
11. Callens C, Adriaens E, Dierckens K, Remon JP. 2001. Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol® 974P on rabbit nasal mucosa and slug mucosa. J Control Rel 76:81-91.
12. Li L, Mathias NR, Stetsko PI, Yu C-D, Smith RL, Wall DA. 2001. Effect of Carbopol 971P mucoadhesive polymer on desmopressin transport in Calu-3 human bronchial epithelial cell culture. AAPS Pharm Sci, Vol. 3, No. 3 (abstract).
13. - secretion. Am J Physiol 266:L493-L501.
14. Foster KA, Avery ML, Yazdanian M, Audus KL. 2000. Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm 208:1-11.
15. Mathias NR, Timoszyk J, Stetsko PI, Megill JR, Smith RL, Wall DA. 2002. Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Targeting 10:31-40.
16. Florea BI, Cassara ML, Junginger HE, Bochard G. 2003. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Rel 87:131-138.
17. Luessen HL, Lehr C-M, Rentel C-O, Noach ABJ, de Boer AG, Verhoef JC, Junginger HE. 1994. Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Rel 29:329-338.
18. Aungst BJ. 2000. Intestinal permeation enhancers. J Pharm Sci 89:429-442.
19. Elgindy NA. 1976. Molecular entrapment of cationic drugs by Carbopol 934. Can J Pharm Sci 11:32-34.
20. Charman WN, Christy DP, Geunin EP, Monkhouse DC. 1991. Interaction between calcium, a model divalent cation, and a range of poly(acrylic acid) resins as a function of solution pH. Drug Dev Ind Pharm 17:271-280.
21. Gumbiner B. 1987. Structure, biochemistry, and assembly of epithelial tight junctions. Am J Physiol 253:C749-C758.
22. Citi S. 1992. Protein Kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells. J Cell Biol 117:169-178.
23. Contreras RG, Ponce A. 1992. Calcium and tight junctions. In Cereijido M, editor. Tight junctions. Boca Raton, FL: CRC Press, pp 139-150.
24. Hochman J, Artusson P. 1994. Mechanisms of absorption enhancement and tight junction regulation. J Control Rel 29:253-267.
25. Balda MS. 1992. Intracellular signals in the assembly and sealing of tight junctions. In Cereijido M, editor. Tight junctions. Boca Raton, FL: CRC Press, pp 121-138.
26. Tozer TN, Bois FY, Hauck WW, Chen ML, Williams RL. 1996. Absorption rates vs. exposure: which is more useful for bioequivalence testing? Pharm Res 13:453-456.
27. Fisher AN, Brown K, Davis SS, Parr GD, Smith DA. 1987. The effect of molecular size on the nasal absorption of water-soluble compounds in the albino rabbit. J Pharm Pharmacol 39: 357-362.
28. Lehr C-M, Poelma FGJ, Junginger HE, Tukker JJ. 1991. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int J Pharm 70:235-240.